A new method for the purification of bioactive insulin-like growth factor-binding protein-3

Protein Expression and Purification

Volumn 71, Issue 2, 2010, Pages 160-167

  Pircher, Haymo ^a   Matscheski, Andrea ^a   Laich, Andreas ^a   Hermann, Martin ^b   Moser, Barbara ^a   Viertler, Hans Peter ^a   Micutkova, Lucia ^a   Lindner, Herbert ^c   Sarg, Bettina ^c   Zwerschke, Werner ^a   Jansen Dürr, Pidder ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b Department of Visceral Transplant and Thoracic Surgery   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Affinity chromatography; IGF binding protein; Purification

Indexed keywords

RECOMBINANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3;

AFFINITY CHROMATOGRAPHY; ARTICLE; FIBROBLAST; HUMAN; METABOLISM; PROTEIN BINDING; SIGNAL TRANSDUCTION;

CHROMATOGRAPHY, AFFINITY; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PROTEIN BINDING; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 77949484722     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.02.005     Document Type: Article

References (36)

1. Valentinis B., and Baserga R. IGF-I receptor signaling in transformation and differentiation. Mol. Pathol. 54 (2001) 133-137
2. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
3. Kurmasheva R.T., and Houghton P.J. IGF-I mediated survival pathways in normal and malignant cells. Biochim. Biophys. Acta 1766 (2006) 1-22
4. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4 (2004) 505-518
5. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor-binding proteins. Endocr. Rev. 23 (2002) 824-854
6. Rajah R., Valentinis B., and Cohen P. Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272 (1997) 12181-12188
7. Cohen P. Insulin-like growth factor-binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 147 (2006) 2109-2111
8. Hong J., Zhang G., Dong F., and Rechler M.M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J. Biol. Chem. 277 (2002) 10489-10497
9. Kim H.S., Ingermann A.R., Tsubaki J., Twigg S.M., Walker G.E., and Oh Y. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res. 64 (2004) 2229-2237
10. Silha J.V., Sheppard P.C., Mishra S., Gui Y., Schwartz J., Dodd J.G., and Murphy L.J. Insulin-like growth factor (IGF)-binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology 147 (2006) 2112-2121
11. Lee K.W., Liu B., Ma L., Li H., Bang P., Koeffler H.P., and Cohen P. Cellular internalization of insulin-like growth factor-binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol. Chem. 279 (2004) 469-476
12. Goda N., Tenno T., Inomata K., Shirakawa M., Tanaka T., and Hiroaki H. Intracellular protein delivery activity of peptides derived from insulin-like growth factor-binding proteins 3 and 5. Exp. Cell Res. 314 (2008) 2352-2361
13. Liu B., Lee K.W., Li H., Ma L., Lin G.L., Chandraratna R.A., and Cohen P. Combination therapy of insulin-like growth factor-binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo. Clin. Cancer Res. 11 (2005) 4851-4856
14. Liu B., Lee K.W., Anzo M., Zhang B., Zi X., Tao Y., Shiry L., Pollak M., Lin S., and Cohen P. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 26 (2007) 1811-1819
15. Conover C.A., Ronk M., Lombana F., and Powell D.R. Structural and biological characterization of bovine insulin-like growth factor-binding protein-3. Endocrinology 127 (1990) 2795-2803
16. Roghani M., Segovia B., Whitechurch O., and Binoux M. Purification from human cerebrospinal fluid of insulin-like growth factor-binding Proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species. Growth Regul. 1 (1991) 125-130
17. Forbes B., Ballard F.J., and Wallace J.C. An insulin-like growth factor-binding protein purified from medium conditioned by a human lung fibroblast cell line (He[39]L) has a novel N-terminal sequence. J. Endocrinol. 126 (1990) 497-506
18. Spratt S.K., Tatsuno G.P., Yamanaka M.K., Ark B.C., Detmer J., Mascarenhas D., Flynn J., Talkington-Verser C., and Spencer E.M. Cloning and expression of human insulin-like growth factor-binding protein 3. Growth Factors 3 (1990) 63-72
19. Tressel T.J., Tatsuno G.P., Spratt K., and Sommer A. Purification and characterization of human recombinant insulin-like growth factor-binding protein 3 expressed in Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 178 (1991) 625-633
20. Firth S.M., Ganeshprasad U., and Baxter R.C. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J. Biol. Chem. 273 (1998) 2631-2638
21. Firth S.M., Ganeshprasad U., Poronnik P., Cook D.I., and Baxter R.C. Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3. Protein Expr. Purif. 16 (1999) 202-211
22. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., and Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp. Gerontol. 36 (2001) 1327-1347
23. Sommer A., Spratt S.K., Tatsuno G.P., Tressel T., Lee R., and Maack C.A. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Regul. 3 (1993) 46-49
24. Conover C.A. Glycosylation of insulin-like growth factor-binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology 129 (1991) 3259-3268
25. Booth B.A., Boes M., Dake B.L., Linhardt R.J., Caldwell E.E., Weiler J.M., and Bar R.S. Structure-function relationships in the heparin-binding C-terminal region of insulin-like growth factor-binding protein-3. Growth Regul. 6 (1996) 206-213
26. Booth B.A., Boes M., Andress D.L., Dake B.L., Kiefer M.C., Maack C., Linhardt R.J., Bar K., Caldwell E.E., Weiler J., et al. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin-binding domain. Growth Regul. 5 (1995) 1-17
27. Cheng G.Z., Park S., Shu S., He L., Kong W., Zhang W., Yuan Z., Wang L.H., and Cheng J.Q. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr. Cancer Drug Targets 8 (2008) 2-6
28. Wolf F., and Geley S. A simple and stable auto focusing protocol for long multidimensional live cell microscopy. J. Microsc. 221 (2006) 72-77
29. Yamada P.M., and Lee K.W. Perspectives in mammalian IGFBP-3 Biology: local vs. systemic action. Am. J. Physiol. Cell Physiol. (2009)
30. Burgess R.R. Refolding solubilized inclusion body proteins. Methods Enzymol. 463 (2009) 259-282
31. Pampusch M.S., Kamanga-Sollo E., White M.E., Hathaway M.R., and Dayton W.R. Effect of recombinant porcine IGF-binding protein-3 on proliferation of embryonic porcine myogenic cell cultures in the presence and absence of IGF-I. J. Endocrinol. 176 (2003) 227-235
32. Hennies M., and Sauerwein H. Purification of bovine IGFBP-3 and the development of an enzyme immunoassay for the protein. J. Immunol. Methods 281 (2003) 9-15
33. Bagnall W., Sharpe P.M., Newham P., Tart J., Mott R.A., Torr V.R., Forder R.A., and Needham M.R. Expression and purification of biologically active IGF-binding proteins using the LCR/Mel expression system. Protein Expr. Purif. 27 (2003) 1-11
34. Burrows C., Holly J.M., Laurence N.J., Vernon E.G., Carter J.V., Clark M.A., McIntosh J., McCaig C., Winters Z.E., and Perks C.M. Insulin-like growth factor-binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 147 (2006) 3484-3500
35. Chan S.S., Twigg S.M., Firth S.M., and Baxter R.C. Insulin-like growth factor-binding protein-3 leads to insulin resistance in adipocytes. J. Clin. Endocrinol. Metab. 90 (2005) 6588-6595
36. Perks C.M., McCaig C., Clarke J.B., Clemmons D.R., and Holly J.M. A non IGF-binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. Biochem. Biophys. Res. Commun. 294 (2002) 988-994